US Senator Kirsten Gillibrand
Gillibrand Announces Legislation To Accelerate FDA Approval Of Drugs To Treat Life-Threatening Illnesses
Today, U.S. Senator Kirsten Gillibrand held a video press conference to announce her bipartisan legislation to expedite provisional FDA approval of drugs intended to treat ALS, Parkinson’s, Alzheimer’s, and other life-threatening diseases. The standard FDA approval process takes many years to get drugs to market, but patients with rapidly progressing illnesses often don’t have many years to wait. Gillibrand’s Promising Pathway Act would accelerate the FDA’s approval process and help get promising treatments to those who need them.